Immunohistochemistry has been utilized in recent years primarily for d
iagnosis of infectious diseases of the liver, especially in humans. Th
e utility of immunohistochemistry has extended to experimental and tox
icologic pathology in a variety of areas: identification of cell pheno
type, cell receptors, cytokine and chemikine production, and functiona
l cell changes such as enzyme induction. In addition, markers for expe
rimental carcinogenesis studies are detectable by immunohistochemical
changes as well as novel antigen induction such as placental glutathio
ne-S-transferase, oncofetal proteins, oncogene products, and typing of
neoplasms. Immunohistochemistry is also used to detect the origin and
function of various cell types in developmental and toxicity studies.
Careful use of immunohistochemical procedures in conjunction with rou
tine pathology and molecular techniques enhance the ability of the tox
icologic pathologist to diagnose unique conditions and to understand m
echanisms of lesion development.